TrialJournal of psychopharmacology (Oxford, England)2024

Beneficial adjunctive effects of the 5HT3 receptor antagonist ondansetron on symptoms, function and cognition in early phase schizophrenia in a double-blind, 2 × 2 factorial design, randomised controlled comparison with simvastatin.

Imran B Chaudhry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.